Risk Model of Cognitive Impairment in Diabetes
NCT05590442 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-03-28
Summary
Development and validation of a risk model for predicting the risk of mild cognitive impairment among individuals of type 2 diabetes.
Conditions
Interventions
- OTHER
-
Tests
Cognitive assessments and olfactory tests
Sponsors & Collaborators
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2024-12-31
- Completion
- 2025-08-31
Countries
- China
Study Locations
More Related Trials
-
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
NCT07128186 ·Status: RECRUITING
-
Relationship Between Diabetes and Cognitive Impairment Based on Olfactory Function Assessment and Functional MRI
NCT02738671 ·Status: COMPLETED
-
Investigating the Insulin Resistance in Individuals With Type 2 Diabetes
NCT06428968 ·Status: RECRUITING ·Phase: NA
-
The Early Warning System for the Diabetic Encephalopathy
NCT02420470 ·Status: RECRUITING
-
Comparison of Cognitive and Motor Dual Task Performance in Individuals With Prediabetes and Diabetes
NCT05203042 ·Status: UNKNOWN
-
Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)
NCT07250789 ·Status: RECRUITING ·Phase: NA
-
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
NCT05313529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Association Between Cognitive Function and Neuropathy in Individuals With Type 2 Diabetes
NCT06857994 ·Status: COMPLETED
-
The Imaging Genetic Study of Type 2 Diabetes and Depression
NCT03564431 ·Status: UNKNOWN
-
Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus）
NCT06912321 ·Status: RECRUITING
-
Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community
NCT06524388 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease
NCT02501876 ·Status: COMPLETED
-
Sweet Sensing in Type 2 Diabetes
NCT06804187 ·Status: ENROLLING_BY_INVITATION
-
Utilizing Glycaemic Index: An Investigation of the Glycaemia and Cognition in Type 2 Diabetes
NCT03360604 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Type 2 Diabetes Mellitus With Cognitive Impairment: a Cohort Study
NCT05728567 ·Status: ACTIVE_NOT_RECRUITING
-
Cognitive Functions and BDNF in T2DM and Prediabetes Patients
NCT05654727 ·Status: COMPLETED
-
Analysis of Relevant Influencing Factors of Glycemic Control in Patients With Diabetes
NCT05854862 ·Status: UNKNOWN
-
DHS MIND Metabolomics
NCT03975309 ·Status: COMPLETED
-
Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)
NCT04304261 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.
NCT00155142 ·Status: UNKNOWN
-
Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
NCT03707171 ·Status: COMPLETED ·Phase: PHASE3
-
A Decentralized Study on Dietary Influences on Cognitive Functions
NCT05801731 ·Status: COMPLETED ·Phase: NA
-
Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design
NCT02149056 ·Status: COMPLETED
-
Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular Diseases
NCT04983277 ·Status: NOT_YET_RECRUITING
-
The Factors Affecting the Achievement of Glucose Monitor in the Patients on Diabetes
NCT03804658 ·Status: UNKNOWN